Medical Excellence Capital, an early-stage life sciences venture fund, and Alexandria Venture Investments, an investment company, led a $15m funding round in Pleno, a technology startup. “The COVID-19 pandemic demonstrated the limitations of our current biological research and testing paradigms in terms of capability, scalability, throughput, and cost. Our technology was born from the desire to enable the simultaneous and rapid detection of more targets, from more samples at a dramatically lower cost, which we believe has the potential to democratize clinical multi-omics and ultimately transform human health.” Pieter van Rooyen, Pleno Founder and CEO.